Immix Biopharma Statistics

Total Valuation

IMMX has a market cap or net worth of $64.45 million. The enterprise value is $36.22 million.

Market Cap	64.45M
Enterprise Value	36.22M

Important Dates

The last earnings date was Thursday, May 9, 2024, after market close.

Earnings Date	May 9, 2024
Ex-Dividend Date	n/a

Share Statistics

IMMX has 26.41 million shares outstanding. The number of shares has increased by 68.65% in one year.

Shares Outstanding	26.41M
Shares Change (YoY)	+68.65%
Shares Change (QoQ)	+35.16%
Owned by Insiders (%)	45.88%
Owned by Institutions (%)	11.58%
Float	14.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.31
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.82, with a Debt / Equity ratio of 0.04.

Current Ratio	5.82
Quick Ratio	n/a
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -94.20% and return on invested capital (ROIC) is -66.22%.

Return on Equity (ROE)	-94.20%
Return on Assets (ROA)	-78.90%
Return on Capital (ROIC)	-66.22%
Revenue Per Employee	n/a
Profits Per Employee	-$1.30M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, IMMX has paid $30,084 in taxes.

Income Tax	30,084
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +39.55% in the last 52 weeks. The beta is 0.24, so IMMX's price volatility has been lower than the market average.

Beta (1Y)	0.24
52-Week Price Change	+39.55%
50-Day Moving Average	2.60
200-Day Moving Average	3.53
Relative Strength Index (RSI)	54.13
Average Volume (30 Days)	174,098

Short Selling Information

The latest short interest is 387,502, so 1.47% of the outstanding shares have been sold short.

Short Interest	387,502
Short Previous Month	349,888
Short % of Shares Out	1.47%
Short % of Float	2.75%
Short Ratio (days to cover)	2.61

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-19.21M
Pretax Income	-18.18M
Net Income	-18.21M
EBITDA	-18.15M
EBIT	-18.18M
Earnings Per Share (EPS)	-$0.93

Full Income Statement

Balance Sheet

The company has $29.32 million in cash and $1.09 million in debt, giving a net cash position of $28.23 million or $1.07 per share.

Cash & Cash Equivalents	29.32M
Total Debt	1.09M
Net Cash	28.23M
Net Cash Per Share	$1.07
Equity / Book Value	27.92M
Book Value Per Share	1.06
Working Capital	27.26M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$13.11 million and capital expenditures -$315,090, giving a free cash flow of -$13.42 million.

Operating Cash Flow	-13.11M
Capital Expenditures	-315,090
Free Cash Flow	-13.42M
FCF Per Share	-$0.57

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

IMMX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-68.65%
Shareholder Yield	-68.65%
Earnings Yield	-28.25%
FCF Yield	-20.82%

Analyst Forecast

The average price target for IMMX is $14.00, which is 466.80% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.00
Price Target Difference	466.80%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1